Several genetic mutations previously linked to breast cancer and included on commercial genetic tests, including direct-to-consumer tests, were found not to increase a woman’s risk of disease, according to a population study of more than 64,000 women published online today in the New England Journal of Medicine from several institutions, including Penn Medicine.
↧
Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals
↧